Home / Locations / Mexico / Mexico City
Mexico City

Mexico City

Mexico

CMS Woodhouse Lorente Ludlow is located in the heart of Mexico City's commercial district. The firm was founded in 2009 and began its formal association with CMS in 2013, formally joining the CMS network in 2018. CMS WLL is highly regarded in the local legal market for its legal expertise, strategic approach and deep knowledge of the sectors in which their clients operate.

From its location in the epicentre of the Americas, CMS Woodhouse Lorente Ludlow's bilingual team provides a full scope of legal services to local and international clients in the areas of Energy, Projects and Infrastructure, Real Estate, Employment, Environmental and Climate Change, Corporate M&A, Banking and Finance, Project Finance, Administrative Law, Technology, Media and Communications, Lifesciences and Healthcare.

As a member of the international law firm CMS, ranked as a Top Ten global law firm, CMS Woodhouse Lorente Ludlow offers you global reach with a presence in more than 40 countries. CMS also offers significant expertise in a wide variety of practice areas and sectors, and over 4,500 lawyers that offer business-focused advice in local markets or globally across multiple jurisdictions.

more less

Directions

Paseo de la Reforma 115, Lomas - Virreyes, Lomas de Chapultepec V Secc, 11000 Ciudad de México, CDMX

Our office is approximately 17km from Aeropuerto Internacional Benito Juárez, between 30 minutes and 1 hour in an Uber depending on the traffic. The journey should cost MXN200-400 (approx. USD10-20).

more less

Location

CMS Woodhouse Lorente Ludlow, S.C.
Paseo de la Reforma 115
Piso 19
Col. Lomas de Chapultepec
Mexico City
Mexico
Open Google Maps

Feed

20/05/2022
Amended IC­SID Rules to enter in­to force on 1 Ju­ly 2022
On 21 March 2022, the Mem­ber States of the In­ter­na­tion­al Centre for Set­tle­ment of In­vest­ment Dis­putes (IC­SID) ad­op­ted a com­pre­hens­ive set of amend­ments to IC­SID ar­bit­ra­tion and con­cili­ation rules (“IC­SID...
19/05/2022
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
Why this guide? In re­cent years can­nabis trade and re­lated activ­ity has de­veloped in­to a growth busi­ness area. In the life sci­ences and health­care fields, there have been in­creases in the num­bers of...
18/05/2022
CMS Ex­pert Guide to trade secrets
Ex­plore and com­pare the pro­tec­tion for trade secrets in your chosen mar­kets. As a busi­ness, your most val­ued as­sets can be the things you can’t touch or see.  In­tan­gible as­sets such as pat­ents, for­mu­las...
Comparable
12/05/2022
10 key as­pects of the re­vised EU com­pet­i­tion law in the field of dis­tri­bu­tion...
The new Ver­tic­al Block Ex­emp­tion Reg­u­la­tion (VBER) and the new ac­com­pa­ny­ing Ver­tic­al Guidelines (VGL) were pub­lished on 10 May 2022. The new VBER will enter in­to force on 1 June 2022 and ap­ply for the...
21/04/2022
En­ergy: Con­sequences of not ex­er­cising an op­tion
In Thurcroft Power Lim­ited v. Volta En­ergy Group Lim­ited [2022] EWHC 338 (Comm), the Com­mer­cial Court de­cided that an op­tion agree­ment con­cern­ing the early stages of a bat­tery stor­age de­vel­op­ment did...
04/2022
CMS Life Sci­ences & Health­care Glob­al Bro­chure
With big deals fuel­ling re­cord levels of M&A activ­ity, a steady stream of in­nov­at­ive and dis­rupt­ive tech­no­lo­gies, new and in­creas­ingly com­plex reg­u­lat­ory chal­lenges and a thriv­ing start-up com­munity...
04/04/2022
Más allá de la marca per­son­al
El se­gundo re­porte de CMS Lat­inoamérica, "Guía para ger­entes le­gales: Más allá de la marca per­son­al”, in­vest­iga sobre la im­port­an­cia de la marca per­son­al (MP) como her­rami­enta para po­ten­ciar la...
29/03/2022
Force Ma­jeure - Hard­ship in re­la­tion to Con­flict and Sanc­tions
The in­va­sion of Ukraine has promp­ted west­ern demo­cra­cies, in­clud­ing the European Uni­on, UK and US, to ini­ti­ate a raft of sanc­tions against Rus­si­an-owned com­pan­ies, and prom­in­ent in­di­vidu­als closely as­so­ci­ated...
Comparable
28/03/2022
The rise of ar­bit­ra­tion in post M&A dis­putes
The CMS European M&A Study 2022 provides an in­sight in­to the M&A-mar­ket and the use of ar­bit­ra­tion in resolv­ing dis­putes res­ult­ing from M&A deals. This study cov­ers over 400 shares and as­sets deals across...
24/03/2022
CMS European M&A Study 2022
The CMS Cor­por­ate/M&A Group is pleased to launch the four­teenth edi­tion of the European M&A Study
14/03/2022
ICC re­port on lever­aging tech­no­logy in in­ter­na­tion­al ar­bit­ra­tion
On 18 Feb­ru­ary 2022, the ICC launched its new com­mis­sion re­port, titled: Lever­aging Tech­no­logy for Fair, Ef­fect­ive and Ef­fi­cient In­ter­na­tion­al Ar­bit­ra­tion Pro­ceed­ings. The con­clu­sions and re­com­mend­a­tions...
03/03/2022
CMS Ex­pert Guide to ad­verse ef­fects of drugs and vac­cines
The glob­al pan­dem­ic has ris­en a grow­ing aware­ness of the risks of ad­verse ef­fects of drugs and vac­cines. This un­ex­pec­ted event has put health­care pro­fes­sion­als in a situ­ation whereby the stand­ard pro­to­cols...
Comparable